Please login to the form below

Not currently logged in
Email:
Password:

WuXi PharmaTech hires for three senior level positions

WuXi PharmaTech hires new staff to three key senior level positions, including executive vice-president of operations, vice-president of toxicology and vice-president of finance

WuXi PharmaTech, a Chinese-headquartered provider of pharmaceutical R&D outsourcing services, has made hires to three key senior level positions, including executive vice-president of operations, vice-president of toxicology and vice-president of finance.

Mr Edward Hu will serve as WuXi PharmaTech's executive vice-president of operations, and will report directly to Dr Ge Li, who is WuXi's chairman and CEO. Hu brings an extensive experience in operations and financial management. Before his appointment with WuXi PharmaTech, he was the senior vice-president and COO of Tanox, where he managed operations, finance, IT, project management and strategic planning. Hu has also held management positions at Biogen Idec and Merck.

Dr Victor H Chen will serve as vice-president and head of toxicology at SuZhou PharmaTech and will report directly to Dr Ge Li, chairman and CEO of the company.

Chen will work closely with Dr Lijie Fu, head of operations at SuZhou PharmaTech to further enhance WuXi's capability and capacity in Toxicology services.

Prior to joining WuXi PharmaTech, Dr. Chen held the position of director of toxicology for ImClone Systems. He has previously held positions at Pfizer and Bristol-Myers Squibb, as well as at the University of Hawaii.

Reporting to Mr Benson Tsang, WuXI's CFO, Christine Lu-Wong has been appointed as vice-president of finance. Lu-Wong has held various finance positions at multi-national companies, such as Hewlett-Packard and Sun Microsystems. Prior to joining WuXi PharmaTech, Lu-Wong consulted many companies in San Jose, California including Google and Altera.

14th August 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics